Revenue: The sum of all revenue fields included for a company's operating activities.
Catalyst Pharmaceuticals, Inc. (CPRX) had Revenue of $491.73M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$491.73M |
$163.89M |
|
$68.84M |
|
$422.89M |
|
$296.61M |
|
$195.12M |
|
$21.14M |
|
$216.26M |
|
$216.26M |
|
$163.89M |
|
$163.89M |
|
$163.89M |
|
$163.89M |
|
$195.12M |
|
$232.90M |
|
118.46M |
|
124.94M |
|
$1.38 |
|
$1.31 |
|
| Balance Sheet Financials | |
$623.61M |
|
$1.35M |
|
$227.80M |
|
$851.41M |
|
$120.68M |
|
-- |
|
$3.10M |
|
$123.78M |
|
$727.63M |
|
$570.96M |
|
$727.63M |
|
120.88M |
|
| Cash Flow Statement Financials | |
$239.81M |
|
$-0.56M |
|
$140.66M |
|
$137.64M |
|
$517.55M |
|
$379.92M |
|
$22.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
86.00% |
|
39.68% |
|
39.68% |
|
47.36% |
|
43.98% |
|
33.33% |
|
$239.25M |
|
-- |
|
-- |
|
-- |
|
0.58 |
|
3.52 |
|
7.51 |
|
48.60 |
|
22.52% |
|
28.70% |
|
19.25% |
|
22.52% |
|
$6.02 |
|
$1.91 |
|
$1.92 |
|